ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure

Aims: Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a cornerstone of drug therapy after myocardial infarction (MI) and improve left ventricular function and survival. We aimed to elucidate the impact of early treatment with the ACE inhibitor ramipril on the hematopoietic response aft...

Full description

Saved in:
Bibliographic Details
Main Authors: Wolf-Stephan Rudi (Author), Michael Molitor (Author), Venkata Garlapati (Author), Stefanie Finger (Author), Johannes Wild (Author), Thomas Münzel (Author), Susanne H. Karbach (Author), Philip Wenzel (Author)
Format: Book
Published: MDPI AG, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_be4a671943a14cb6aad076c20cc2e89a
042 |a dc 
100 1 0 |a Wolf-Stephan Rudi  |e author 
700 1 0 |a Michael Molitor  |e author 
700 1 0 |a Venkata Garlapati  |e author 
700 1 0 |a Stefanie Finger  |e author 
700 1 0 |a Johannes Wild  |e author 
700 1 0 |a Thomas Münzel  |e author 
700 1 0 |a Susanne H. Karbach  |e author 
700 1 0 |a Philip Wenzel  |e author 
245 0 0 |a ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure 
260 |b MDPI AG,   |c 2021-03-01T00:00:00Z. 
500 |a 10.3390/antiox10030396 
500 |a 2076-3921 
520 |a Aims: Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a cornerstone of drug therapy after myocardial infarction (MI) and improve left ventricular function and survival. We aimed to elucidate the impact of early treatment with the ACE inhibitor ramipril on the hematopoietic response after MI, as well as on the chronic systemic and vascular inflammation. <i>Methods and Results:</i> In a mouse model of MI, induced by permanent ligation of the left anterior descending artery, immediate initiation of treatment with ramipril (10 mg/k/d via drinking water) reduced cardiac inflammation and the number of circulating inflammatory monocytes, whereas left ventricular function was not altered significantly, respectively. This effect was accompanied by enhanced retention of hematopoietic stem cells, Lin<sup>−</sup>Sca1<sup>−</sup>c-Kit<sup>+</sup>CD34<sup>+</sup>CD16/32<sup>+</sup> granulocyte-macrophage progenitors (GMP) and Lin<sup>−</sup>Sca1<sup>−</sup>c-Kit<sup>+</sup>CD150<sup>−</sup>CD48<sup>−</sup> multipotent progenitors (MPP) in the bone marrow, with an upregulation of the niche factors Angiopoetin 1 and Kitl at 7 d post MI. Long-term ACE inhibition for 28 d limited vascular inflammation, particularly the infiltration of Ly6C<sup>high</sup> monocytes/macrophages, and reduced superoxide formation, resulting in improved endothelial function in mice with ischemic heart failure. <i>Conclusion:</i> ACE inhibition modulates the myeloid inflammatory response after MI due to the retention of myeloid precursor cells in their bone marrow reservoir. This results in a reduction in cardiac and vascular inflammation with improvement in survival after MI. 
546 |a EN 
690 |a myocardial infarction 
690 |a ACE inhibitors 
690 |a emergency hematopoiesis 
690 |a vascular inflammation 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 10, Iss 3, p 396 (2021) 
787 0 |n https://www.mdpi.com/2076-3921/10/3/396 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/be4a671943a14cb6aad076c20cc2e89a  |z Connect to this object online.